Books: 'Throat Diseases Treatment'

1

Anṣārī, Muḥammad Yūsuf. Uz̲n, anf va ḥalq: Maʻ imrāz̤-i lisān, asnān aur lathah. Naʾī Dihlī: Iʻjāz Pablishing Hāʾūs, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Blonigen, Julie A. Treatment of vocal hoarseness in children: Julie A. Blonigen. 2nd ed. Austin, Tex: Pro-Ed, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

United States. Congress. House. Committee on International Relations. Infectious diseases: A growing threat to America's health and security : hearing before the Committee on International Relations, House of Representatives, One Hundred Sixth Congress, second session, June 29, 2000. Washington: U.S. G.P.O., 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

United States. Congress. House. Committee on International Relations. Infectious diseases: A growing threat to America's health and security : hearing before the Committee on International Relations, House of Representatives, One Hundred Sixth Congress, second session, June 29, 2000. Washington: U.S. G.P.O., 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Reagan, Ronald. AIDS initiatives: Message from the President of the United States transmitting a 10-point action plan to respond to the public health threat posed by the human immunodeficiency virus. Washington: U.S. G.P.O., 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Progress since September 11th: Protecting public health and safety of the responders and residents : hearing before the Subcommittee on National Security, Emerging Threats, and International Relations of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, September 8, 2006. Washington: U.S. G.P.O., 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Office, General Accounting. VA health care: Further efforts needed to improve hepatitis C testing for at-risk veterans : report to the Chairman, Subcommittee on National Security, Emerging Threats, and International Relations, Committee on Government Reform, House of Representatives. Washington, D.C: United States General Accounting Office, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Parker, Charles Arthur. A Guide to Diseases of the Nose and Throat and Their Treatment. Arkose Press, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Lydiatt, MD William M., and MD Perry Johnson. Cancers of the Mouth and Throat: A Patient's Guide to Treatment. Addicus Books, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Ingals, E. Fletcher. Lectures On The Diagnosis And Treatment Of Diseases Of The Chest, Throat And Nasal Cavities. Kessinger Publishing, LLC, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Ingals, E. Fletcher. Lectures On The Diagnosis And Treatment Of Diseases Of The Chest, Throat And Nasal Cavities. Kessinger Publishing, LLC, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Diseases of the throat & lungs: A practical treatise on consumption, bronchitis, asthma and kindred diseases, with a description of their treatment by inhalation. Toronto: Hunter & Malcolm, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

1950-, Stair Thomas O., ed. Practical management of eye, ear, nose, mouth, and throat emergencies. Rockville, Md: Aspen Systems, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Scheppegrell, William. Electricity In The Diagnosis And Treatment Of Diseases Of The Nose, Throat And Ear. Kessinger Publishing, LLC, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Scheppegrell, William. Electricity In The Diagnosis And Treatment Of Diseases Of The Nose, Throat And Ear. Kessinger Publishing, LLC, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Seiler, Carl. Handbook of the Diagnosis and Treatment of the Diseases of the Throat, Nose, and Naso-Pharynx. Creative Media Partners, LLC, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Anthony, Hill. ÁMOXICILLIŃ: Effective Medication for the Treatment of Skin Diseases, Urinary Tract Infections, Strep Throat Pneumonia and Gonorrhea. Independently Published, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Dave, Anthony. ÁmoxicilliŃ: Effective Medication for the Treatment of Skin Diseases, Urinary Tract Infections, Strep Throat Pneumonia and Gonorrhea. Independently Published, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Scott, Shaquan. ÁmoxicilliŃ: Effective Medication for the Treatment of Skin Diseases, Urinary Tract Infections, Strep Throat Pneumonia and Gonorrhea. Independently Published, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

John, Job. Anti Infection: Successful Medication for the Treatment of Skin Illnesses, Urinary Tract Diseases, Strep Throat Pneumonia and Gonorrhea. Independently Published, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

John, Job. Anti Infection: Successful Medication for the Treatment of Skin Illnesses, Urinary Tract Diseases, Strep Throat Pneumonia and Gonorrhea. Independently Published, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Chanmugam, Arjun S., Richard Rothman, Sanjay Desai, and Shannon Putman, eds. Infectious Diseases Emergencies. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.001.0001.

Full text

Abstract:

Infectious Diseases Emergencies is a compact reference that summarizes the key topics of those infectious disease processes that are most commonly seen in emergency departments, clinics, and urgent care facilities. The opening section reviews principles of infectious disease management and general management of severe infections in acute and emergency environments. The following sections provide a “head-to-toe” synopsis of common infections presenting in both outpatient and acute care settings, including the following human areas: central nervous system; ear, nose, and throat; ocular; cardiovascular; pulmonary; gastrointestinal; genitourinary; skin and soft tissue; and bone and joint. The concluding sections discuss vector-borne infections, infections in special populations, bioterrorism, and finally antibiotic resistance. Each chapter covers some basic elements of the disease, epidemiology, diagnosis and tests, organisms involved, treatment, and other key issues. Concisely written and consistently organized chapters outline the most useful elements of diagnosis and treatment for easy memorization and clarity.

APA, Harvard, Vancouver, ISO, and other styles

23

Cummings, Jeffrey L., and Jagan A. Pillai. Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0001.

Full text

Abstract:

Neurodegenerative diseases (NDDs) are growing in frequency and represent a major threat to public health. Advances in scientific progress have made it clear that NDDs share many underlying processes, including shared intracellular mechanisms such as protein misfolding and aggregation, cell-to-cell prion-like spread, growth factor signaling abnormalities, RNA and DNA disturbances, glial cell changes, and neuronal loss. Transmitter deficits are shared across many types of disorders. Means of studying NDDs with human iPS cells and transgenic models are similar. The progression of NDDs through asymptomatic, prodromal, and manifest stages is shared across disorders. Clinical features of NDDs, including cognitive impairment, disease progression, age-related effects, terminal stages, neuropsychiatric manifestations, and functional disorders and disability, have many common elements. Clinical trials, biomarkers, brain imaging, and regulatory aspects of NDD can share information across NDDs. Disease-modifying and transmitter-based therapeutic interventions, clinical trials, and regulatory approaches to treatments for NDDs are also similar.

APA, Harvard, Vancouver, ISO, and other styles

24

Ingram, Cass, and Cassim Igram. The Respiratory Solution: How to Use Natural Cures to Reverse Respiratory Ailments : Finally, Relief from Asthma, Bronchitis, Mold, Sinus Attacks, Allergies, Sore Throats, cold. Knowledge House Publishers, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Cui, Zhao, Neil Turner, and Ming-hui Zhao. Antiglomerular basement membrane disease. Edited by Neil Turner. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0073_update_001.

Full text

Abstract:

Cyclophosphamide and plasma exchange are the standard of care in rapidly progressive glomerulonephritis or lung haemorrhage caused by antiglomerular basement membrane (anti-GBM) disease, and it is unusual to encounter patients at earlier stages. Steroids are universally used in addition. There is some evidence that plasma exchange may not be a critical part of treatment at an earlier stage. There is no more than anecdotal evidence for other therapies. Slower-onset therapies such as antibodies to B cells are rarely appropriate. If untreated, patients with severe anti-GBM disease will not recover renal function and are at risk of pulmonary haemorrhage. Evidence for the pathogenicity of circulating anti-GBM antibodies provides rationale for removal of circulating antibodies as rapidly as possible, whilst simultaneously inhibiting their synthesis. This was behind the introduction of the combination of plasma exchange with immunosuppressive therapy in mid 1970s, which revolutionized outcomes. Plasmapheresis aims to remove circulating pathogenic antibodies against GBM and possibly other mediators; cyclophosphamide prevents further synthesis of autoantibodies; and steroids act as anti-inflammatory agents to attenuate the glomerular inflammatory response initiated by anti-GBM antibodies. It is clear from experimental models and occasional observations in man that the anti-cell mediated effects of current therapies are important too. Outcomes vary, but in general patient survival is now good, while renal survival remains poor, in many series less than 50% at 1 year. Treatment is toxic and after an early peak in deaths due to pulmonary haemorrhage, secondary infections are the next threat. It may therefore be best not to immunosuppress patients with a very poor renal prognosis who appear to be at low risk of pulmonary haemorrhage. Treatment can usually be curtailed after 3 months without recurrence. ANCA and anti-GBM antibodies occur together in some patients. This is typically an older group which often has features of vasculitis, and the anti-GBM response may often be secondary. Longer treatment as for small vessel vasculitis is usually indicated.

APA, Harvard, Vancouver, ISO, and other styles

26

Temesgen, Zelalem, ed. Mayo Clinic Infectious Diseases Board Review. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199827626.001.0001.

Full text

Abstract:

While infections have always played an important role in the history of mankind, advances in science and technology as well as rapid globalization have resulted in an unprecedented wave of new and old infections thrust into the limelight. The recent pandemic of H1N1 influenza virus infection demonstrates the recurrent theme of emerging and reemerging pathogens that continue to impact public health and patient care areas. Drug resistance among various organisms (not limited to bacteria) has unfortunately become the expectation and, not infrequently, we have been left with few or no efficacious treatment options, an experience not witnessed in more than 7 decades. Human immunodeficiency virus infection continues to challenge our abilities to provide the desired level of care in most areas of the world. Novel syndromes of infection continue to be defined as newer forms of immunosuppression and the development of unique medical devices become standard practice in all areas of medicine and surgery. For trainees and practitioners in the field of infectious diseases today, these factors mandate intense study to establish an expertise in the field that is required to provide best practices now and beyond. This board review will be pivotal in that education. This book is designed and intended primarily for infectious diseases trainees and practitioners preparing for the infectious disease subspecialty examination of the American Board of Internal Medicine. We believe that this book will also be useful to infectious diseases practitioners as well as general internists and other clinicians who desire a comprehensive but practical overview of contemporary infectious diseases topics.

APA, Harvard, Vancouver, ISO, and other styles

27

Karen, Bellenir, and Dresser Peter D, eds. Contagious and non-contagious infectious diseases sourcebook: Basic information about contagious diseases like measles, polio, hepatitis B, and infectious mononucleosis, non-contagious infectious diseases like tetanus and toxic shock syndrome, and diseases occurring as secondary infections such as shingles and Reye syndrome along with vaccination, prevention, and treatment information and a section describing emerging infectious disease threats. Detroit, MI: Omnigraphics, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Gleń-Karolczyk, Katarzyna. Zabiegi ochronne kształtujące plonowanie zdrowotność oraz różnorodność mikroorganizmów związanych z czernieniem pierścieniowym korzeni chrzanu (Atmoracia rusticana Gaertn.). Publishing House of the University of Agriculture in Krakow, 2019. http://dx.doi.org/10.15576/978-83-66602-39-7.

Full text

Abstract:

Horseradish roots, due to the content of many valuable nutrients and substances with healing and pro-health properties, are used more and more in medicine, food industry and cosmetics. In Poland, the cultivation of horseradish is considered minor crops. In addition, its limited size causes horseradish producers to encounter a number of unresolved agrotechnical problems. Infectious diseases developing on the leaves and roots during the long growing season reduce the size and quality of root crops. The small range of protection products intended for use in the cultivation of horseradish generates further serious environmental problems (immunization of pathogens, low effectiveness, deterioration of the quality of raw materials intended for industry, destruction of beneficial organisms and biodiversity). In order to meet the problems encountered by horseradish producers and taking into account the lack of data on: yielding, occurrence of infectious diseases and the possibility of combating them with methods alternative to chemical ones in the years 2012–2015, rigorous experiments have been carried out. The paper compares the impact of chemical protection and its reduced variants with biological protection on: total yield of horseradish roots and its structure. The intensification of infectious diseases on horseradish leaves and roots was analyzed extensively. Correlations were examined between individual disease entities and total yield and separated root fractions. A very important and innovative part of the work was to learn about the microbial communities involved in the epidemiology of Verticillium wilt of horseradish roots. The effect was examined of treatment of horseradish cuttings with a biological preparation (Pythium oligandrum), a chemical preparation (thiophanate-methyl), and the Kelpak SL biostimulator (auxins and cytokinins from the Ecklonia maxima algae) on the quantitative and qualitative changes occurring in the communities of these microorganisms. The affiliation of species to groups of frequencies was arranged hierarchically, and the biodiversity of these communities was expressed by the following indicators: Simpson index, Shannon–Wiener index, Shannon evenness index and species richness index. Correlations were assessed between the number of communities, indicators of their biodiversity and intensification of Verticillium wilt of horseradish roots. It was shown that the total yield of horseradish roots was on average 126 dt · ha–1. Within its structure, the main root was 56%, whereas the fraction of lateral roots (cuttings) with a length of more than 20 cm accounted for 26%, and those shorter than 20 cm for 12%, with unprofitable yield (waste) of 6%. In the years with higher humidity, the total root yield was higher than in the dry seasons by around 51 dt · ha–1 on average. On the other hand, the applied protection treatments significantly increased the total yield of horseradish roots from 4,6 to 45,3 dt · ha–1 and the share of fractions of more than 30 cm therein. Higher yielding effects were obtained in variants with a reduced amount of foliar application of fungicides at the expense of introducing biopreparations and biostimulators (R1, R2, R3) and in chemical protection (Ch) than in biological protection (B1, B2) and with the limitation of treatments only to the treatment of cuttings. The largest increments can be expected after treating the seedlings with Topsin M 500 SC and spraying the leaves: 1 × Amistar Opti 480 SC, 1 × Polyversum WP, 1 × Timorex Gold 24 EC and three times with biostimulators (2 × Kelpak SL + 1 × Tytanit). In the perspective of the increasing water deficit, among the biological protection methods, the (B2) variant with the treatment of seedlings with auxins and cytokinins contained in the E. maxima algae extract is more recommended than (B1) involving the use of P. oligandrum spores. White rust was the biggest threat on horseradish plantations, whereas the following occurred to a lesser extent: Phoma leaf spot, Cylindrosporium disease, Alternaria black spot and Verticillium wilt. In turn, on the surface of the roots it was dry root rot and inside – Verticillium wilt of horseradish roots. The best health of the leaves and roots was ensured by full chemical protection (cuttings treatment + 6 foliar applications). A similar effect of protection against Albugo candida and Pyrenopeziza brassicae was achieved in the case of reduced chemical protection to one foliar treatment with synthetic fungicide, two treatments with biological preparations (Polyversum WP and Timorex Gold 24 EC) and three treatments with biostimulators (2 × Kelpak SL, 1 × Tytanit). On the other hand, the level of limitation of root diseases comparable with chemical protection was ensured by its reduced variants R3 and R2, and in the case of dry root rot, also both variants of biological protection. In the dry years, over 60% of the roots showed symptoms of Verticillium wilt, and its main culprits are Verticillium dahliae (37.4%), Globisporangium irregulare (7.2%), Ilyonectria destructans (7.0%), Fusarium acuminatum (6.7%), Rhizoctonia solani (6.0%), Epicoccum nigrum (5.4%), Alternaria brassicae (5.17%). The Kelpak SL biostimulator and the Polyversum WP biological preparation contributed to the increased biodiversity of microbial communities associated with Verticillium wilt of horseradish roots. In turn, along with its increase, the intensification of the disease symptoms decreased. There was a significant correlation between the richness of species in the communities of microbial isolates and the intensification of Verticillium wilt of horseradish roots. Each additional species of microorganism contributed to the reduction of disease intensification by 1,19%.

APA, Harvard, Vancouver, ISO, and other styles

29

Bowles, David, James Swaby, and Harold Harlan. Guide to Venomous and Medically Important Invertebrates. CSIRO Publishing, 2018. http://dx.doi.org/10.1071/9781486308859.

Full text

Abstract:

Though many are harmless and even beneficial, invertebrates are some of the world’s most feared and dangerous creatures. Guide to Venomous and Medically Important Invertebrates describes the health threats posed by invertebrate groups worldwide, from physical pain and annoyance to disease transmission risk. Featuring clear photographs, distribution maps and descriptions of biological, physical and behavioural characteristics of key groups, this book aids identification of potentially harmful invertebrates. It also summarises personal protection measures to reduce the risk of attack and disease, and provides guidance on treatment. This book will help to protect the health of travellers and serve as a reference for medical personnel working in high-risk areas, as well as those interested in entomology.

APA, Harvard, Vancouver, ISO, and other styles

30

Frid, Christopher L. J., and Bryony A. Caswell. Marine Pollution. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780198726289.001.0001.

Full text

Abstract:

We use more than 100 000 chemicals in our daily lives to promote health, treat disease, facilitate transportation, use in industrial processes, grow food and access clean water. While these developments have improved human lives, many of these compounds ultimately end up in our seas and oceans where they represent a threat to marine life, ourselves and our continued use of the oceans to treat our waste, provide us with food and offer us recreation. Many of the pollution problems of previous decades seem to have been resolved, in the developed world, or at least managed to minimise their environmental impacts. However, despite treatments being available that reduce their damaging qualities, a potent mixture of toxic compounds enter the marine environment every day along with other potentially harmful additions including heat, noise and light and non-native species. The question thus arises: is pollution a problem that has really been solved? How well are we managing traditional pollutants? What are the challenges we still face today? What are the upcoming marine pollution challenges that face society? This volume describes the different marine pollutants, the science behind measuring their ecological impacts and how they are monitored in the environment, including traditional and new management approaches. This is an up-to-date account of marine pollution within the broad ecological and social context of a growing, technologically advanced, global population.

APA, Harvard, Vancouver, ISO, and other styles

31

Soulsby, Lord. Antimicrobial resistance: animal use of antibiotics. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780198570028.003.0005.

Full text

Abstract:

The evolution of resistance to microbes is one of the most significant problems in modern medicine, posing serious threats to human and animal health. The early work on the use of antibiotics to bacterial infections gave much hope that infectious diseases were no longer a problem, especially in the human field. However, as their use, indeed over use, progressed, resistance (both mono-resistance and multi-resistance), which was often transferable between different strains and species of bacteria, emerged. In addition, the situation is increasingly complex, as various mechanisms of resistance, including a wide range of β -lactamases, are now complicating the issue. The use of antibiotics in animals, especially those used for growth promotion, has come in for serious criticism, especially those where their use should be reserved for difficult human infections. To lend control, certain antibiotic growth promoters have been banned from use in the EU and the UK.It is now a decade since the UK House of Lords Science and Technology Committee (1998) highlighted concerns about antimicrobial resistance and the dangers to human health of resistant organisms derived from animals fed antibiotics for growth promotion or the treatment of infectious diseases. The concern expressed in the House of Lords report was similar to that in other major reports on the subject, for example from the World Health Organization, the Wellcome Foundation, the Advisory Committee on the Microbiological Safety of Food and the Swann Report (1969) in which it was recommended that antibiotics used in human medicine should not be used as growth promoters in animals. At the press conference to launch the Lord’s Report it was emphasized that unless serious attention was given to dealing with resistance ‘we may find ourselves returning to a pre-antibiotic era’. The evolution of resistance is one of the significant problems in modern medicine, a much changed situation when the early work on antibiotics gave hope that infectious diseases were no longer a problem, especially in the human field. Optimism was so strong that the Surgeon General of the USA, William H Stewart, in 1969 advised the US Congress that ‘it is time to close the book on infectious diseases and to declare that work against the pestilence is over’. This comment was not only mistaken but it was also damaging to human health undertakings and also reduced funding for research on infectious diseases.Despite the widespread support for and dependence on antibiotics, resistance was increasingly reported worldwide and to recognize the global problem a group of medical workers established in 1981, at Tufts University, the Alliance for the Prudent use of Antibiotics (APUA). This now has affiliated chapters on over 60 countries, many in the developing world. APUA claims to be the ‘world’s leading organization conducting antimicrobial resistance research, education, capacity building and advocacy at the global and grass roots levels’.

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic 'Throat Diseases Treatment'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles